The results showed that overexpression of RUVBL2 was associated with survival in breast cancer patients and that overexpression of RUVBL1 was associated with survival in liver cancer and cervical squamous cell carcinoma patients (Fig. 8h, Supplementary Fig. 8f). Here, RUVBL2 is linked to breast cancer.